Targeting the viral‐entry facilitators of SARS‐CoV‐2 as a therapeutic strategy in COVID‐19-Reference-Cited by-同舟云学术

Targeting the viral‐entry facilitators of SARS‐CoV‐2 as a therapeutic strategy in COVID‐19

Published:2021-05-03 Issue:9 Volume:93 Page:5260-5276
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Muralidar Shibi¹²^ORCID,Gopal Gayathri¹²^ORCID,Visaga Ambi Senthil¹²^ORCID

Affiliation:

1. Biopharmaceutical Research Lab, Anusandhan Kendra‐1 SASTRA Deemed‐to‐be‐University Thanjavur Tamil Nadu India

2. School of Chemical and Biotechnology SASTRA Deemed‐to‐be‐University Thanjavur Tamil Nadu India

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27019

Reference109 articles.

1. World Health Organization. (WHO). Novel Coronavirus (2019‐nCoV) Situation Report—1 21 January 2020.WHO Bull.2020;(January):1‐7.

2. World Health Organization. COVID‐19 Weekly Epidemiological Update 22. World Health Organization.2020;(December):1‐3.https://www.who.int/docs/default-source/coronaviruse/situation-reports/weekly_epidemiological_update_22.pdf

3. The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2

4. A pneumonia outbreak associated with a new coronavirus of probable bat origin

5. Structural basis for the recognition of SARS‐CoV‐2 by full‐length human ACE2;Wu C;Science (80‐),2020

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperglycemia induced cathepsin L maturation linked to diabetic comorbidities and COVID-19 mortality;eLife;2024-08-16

2. Hyperglycemia induced cathepsin L maturation linked to diabetic comorbidities and COVID-19 mortality;eLife;2024-08-16

3. A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers;Frontiers in Immunology;2024-08-15

4. SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron variant of SARS-CoV-2;Antiviral Research;2024-07

5. Hyperglycemia-induced cathepsin L maturation: Linking to diabetic comorbidities and COVID-19 mortality;2024-05-15